NVS:NYSE
Novartis AG
$153.12
arrow_downward
-0.17%(-0.26) 1D
$152.87
arrow_downward
-0.16% (-0.25)todayPre-market
Closed: Jun 24, 4:00:03 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NVS...
Open
$154.20
High
$154.96
Low
$152.30
Mkt. cap
309.64B
Avg. vol.
1.61M
Volume
3.87K
Dividend
3.10%
Quarterly dividend
$1.19
Ex-dividend date
Mar 10, 2026
P/E ratio
21.95
52-wk high
$170.46
52-wk low
$112.34
EPS
$6.98
Beta
0.44
Shares outstanding
2.03B
No. of employees
75K
Open
$154.20
High
$154.96
Low
$152.30
Mkt. cap
309.64B
Avg. vol.
1.61M
Volume
3.87K
Dividend
3.10%
Quarterly dividend
$1.19
Ex-dividend date
Mar 10, 2026
P/E ratio
21.95
52-wk high
$170.46
52-wk low
$112.34
EPS
$6.98
Beta
0.44
Shares outstanding
2.03B
No. of employees
75K
News stories
From sources across the web
Yahoo Finance
·
19 hours ago
Novartis targets undruggable cancers with $1.9bn Antares Therapeutics deal
Yahoo Finance
·
21 hours ago
Antares Therapeutics signs potential $1.9 billion cancer drug deal with Novartis
Business Wire
·
23 hours ago
Antares Therapeutics Enters Agreement with Novartis to Discover, Develop and Commercialize First-in-Class Cancer Therapies
Ad-hoc-news.de
·
1 day ago
Novartis highlights pipeline progress, shares trade steadily on NYSE
Profile
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
About Novartis AG
CEOVasant Narasimhan
Employees75.3K
FoundedFeb 29, 1996
HeadquartersBasel, Basel City, Switzerland
SectorPharmaceutical industry
Websitenovartis.com
AI content may include mistakes. Learn more